ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE

ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE

At present, there is a tendency in Russia to switch domestic manufacturers of drugs from the system of purchases of chemical products to own production of active pharmaceutical ingredients. The article reviews the current state of production of active pharmaceutical substances in the Russian Federat...

Full description

Bibliographic Details
Main Authors:	K. O. Sidorov, A. A. Lin, N. V. Marchenko
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	афс фармацевтические субстанции фармацевтическая промышленность
Online Access:	https://www.pharmjournal.ru/jour/article/view/532

Similar Items

Pharmaceutical Industry Development in the Midst of Crisis: Global Trends
by: Z. A. Mamedyarov
Published: (2020-12-01)

THE MANUFACTURING OF PHARMACEUTICAL INGREDIENTS IN RUSSIAN FEDERATION: THE CRISIS AT THE TURN OF XX TO XXI CENTURIES
by: E. V. Denisova
Published: (2019-01-01)

The Influence of Deuterium on the Properties of Pharmaceutical Substances (Review)
by: A. V. Syroeshkin, et al.
Published: (2020-05-01)

STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES
by: S. A. Kedik, et al.
Published: (2019-01-01)

ANALYSIS OF THE PERSONNEL POTENTIAL EFFICIENCY OF THE PHARMACEUTICAL INSTITUTION
by: Марина Юрьевна Клищенко, et al.
Published: (2017-03-01)

RESULTS OF IMPORT SUBSTITUTION ANALYSIS OF ANTI-CANCER MEDICATIONS IN THE RUSSIAN FEDERATION (2013–2018)
by: O. A. Ryzhova, et al.
Published: (2019-05-01)

THE RELEVANCE OF ASSESSING PATIENT COMPLIANCE IN OCCUPATIONAL DISEASES IN THE SYSTEM OF SPECIALIZED PHARMACEUTICAL CARE
by: Андрей Георгиевич Петров, et al.
Published: (2023-12-01)

Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
by: Z. A. Mamedyarov
Published: (2017-04-01)

Indolo[2,3-a]carbazole Derivatives with Antitumor Activity and Instrumental Methods for Their Investigation (Review)
by: D. A. Kozin, et al.
Published: (2020-11-01)

IMPROVEMENT OF QUALITY REQUIREMENTS FOR CRUDE HERBAL DRUGS OF FRUCTUS CARVI, FRUCTUS FOENICULI AND FRUCTUS ANISI VULGARIS
by: I. A. Samylina, et al.
Published: (2019-01-01)

The role of family anamnesis investigation in antiphospholipid syndrome
by: N. N. Chapayeva, et al.
Published: (2009-04-01)

Responsibilities of the Marketing Authorisation Holders in Respect of GMP Compliance (Review)
by: A. P. Meshkovskiy, et al.
Published: (2020-11-01)

Trade policy of the Russian federation in respect of pharmaceutical products in light of WTO accession
by: Yu K Zaytsev, et al.
Published: (2013-12-01)

DISINTEGRANTS AND THEIR INFLUENCE ON THE DISSOLUTION OF SUBSTANCES OF BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASSES
by: I. E. Smekhova, et al.
Published: (2019-01-01)

THE RELEVANCE OF RAISING AWARENESS OF PHARMACEUTICAL WORKERS ON HIV INFECTION
by: Андрей Георгиевич Петров, et al.
Published: (2023-08-01)

Main features and problems of the Kaluga region innovative pharmaceutical cluster development
by: I I Bogachev, et al.
Published: (2014-12-01)

THE IMPORTANCE OF CHROMATOGRAPHICALLY PURIFIED EXCIPIENTS
by: G. J. Rizzo, et al.
Published: (2019-01-01)

Procedure for Reviewing Pharmaceutical Inspections in the Eurasian Economic Union (Review)
by: A. P. Meshkovskiy, et al.
Published: (2021-08-01)

RESEARCH ON THE INFLUENCE OF VARIOUS SUBSTANCES ON CASPASE ACTIVITY (REVIEW)
by: E. S. Kokareva, et al.
Published: (2019-01-01)

Documentation of Pharmaceutical Development. Part 2. Quality System Documents
by: I. E. Smekhova, et al.
Published: (2021-05-01)

PROBLEMS AND PROSPECTS OF PHARMACEUTICAL PREVENTION IN PROFESSIONAL DISEASES
by: Андрей Георгиевич Петров, et al.
Published: (2020-07-01)

Change in time of spectral characteristics of drug substances (nir region)
by: T E Elizarova, et al.
Published: (2011-09-01)

FEATURES OF ACCOUNTING AND INDIRECT COSTS SHARING IN PRODUCTION IN THE PHARMACEUTICAL INDUSTRY
by: N. Ershova, et al.
Published: (2016-01-01)

FEATURES OF ACCOUNTING AND INDIRECT COSTS SHARING IN PRODUCTION IN THE PHARMACEUTICAL INDUSTRY
by: N. Ershova, et al.
Published: (2019-02-01)

THE PROCEDURE OF ACTIVE PHARMACEUTICAL INGREDIENT SUPPLIERS PRELIMINARY CHOICE FOR MEDICINE MANUFACTURE
by: S. A. Zaitsev, et al.
Published: (2019-01-01)

CONCEPTUAL MODEL OF ECONOMICAL SAFETY MANAGEMENT OF A PHARMACY ORGANIZATION
by: D. A. Kuznetsov, et al.
Published: (2015-10-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

STUDY FOR METHODOLOGICAL SUPPORT ORGANIZATION FOR QUALITUY ESTIMATION OF PHARMACEUTICAL SERVICES IN PHYTOTHERAPY AT THE CAUCASIAN MINERAL WATERS RESORTS
by: L. V. Popov, et al.
Published: (2015-09-01)

MODELING PROCESS OF PALLIATIVE PHARMACEUTICAL CARE AS A COMPONENT OF PHARMACEUTICAL SAFETY AT THE LOCAL LEVEL
by: I. A. Tueva, et al.
Published: (2018-07-01)

STUDY OF TECHNOLOGICAL PROPERTIES OF SUBSTANCE AND BASIC COMPOSITION FOR OBTAINING THE DRUG PRODUCT OF “BIOMAYRIN”
by: N. E. Mamatmusaeva, et al.
Published: (2018-01-01)

MARKETING STUDIES OF ADDITIONAL SERVICES RENDERED IN PHARMACEUTICAL ORGANIZATIONS OF THE REPUBLIC OF NORTH OSSETIA – ALANIA
by: L. N. Tsarakhova, et al.
Published: (2015-12-01)

CONCEPTS OF RISK MANAGEMENT RESEARCH AS A BASIS FOR UNDERSTANDING THE REDUCTION OF RISK EVENTS OF PHARMACEUTICAL ORGANIZATIONS
by: Андрей Георгиевич Петров, et al.
Published: (2022-06-01)

PROJECT-ORIENTED APPROACH TO FINISHED PHARMA PRODUCT DEVELOPMENT IN THE CONTEXT OF GENERIC POLYCOMPONENT DRUG CONTAINING AMOXYCILLIN AND CLAVULANIC ACID
by: Yu. V. Vlasenko
Published: (2019-01-01)

The Integrated Model of Quality Management System of Laboratory Studies of Medicines (Review)
by: A. I. Selezneva, et al.
Published: (2021-08-01)

Increase of compliance of chronic patients as aspects of pharmaceutical care
by: I A Kirschina, et al.
Published: (2013-12-01)

Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site
by: I. E. Smekhova, et al.
Published: (2021-02-01)

DEVELOPMENT AND VALIDATION OF THE METHOD OF KINETIC EVALUATION OF MEDICAL SUBSTANCE TOPIRAMAT DISSOLUTION BY LASER DIFFRACTION OF LIGHT METHOD
by: E. V. Uspenskaya, et al.
Published: (2019-01-01)

Medicines management — modern paradigm for pharmacy practice
by: Ye. V. Karakulova, et al.
Published: (2012-12-01)

CONCEPTUALLY-THEORETICAL JUSTIFICATION AND UPDATING OF THE PREVENTIVE APPROACH IN THE IMPLEMENTATION OF A PHARMACIST’S INFORMATION CONSULTANCY SERVICES IN THE PUBLIC HEALTH SYSTEM
by: I. A. Kirshchina, et al.
Published: (2020-12-01)

ANALYSIS OF SCIENTIFIC RESEARCHES IN PHARMACEUTICAL PROMOTION GLOBALLY: TOWARDS INTERNATIONALLY DEVELOPING PRACTICALLY-ORIENTED GUIDELINES FOR PHARMACEUTICAL COMPANIES
by: M. M. Bahlol, et al.
Published: (2016-03-01)